Atai Life Sciences
Series CAtai Life Sciences raised €105M in a Series C round in Nov 2020. The company is based in Munich, Germany. Data as of 4 Nov 2026.
Amount raised
€105M
€105,369,637
Native amount
125,000,000 USD
Stage
Series C
series c
Investors
0
Provenance & confidence
High confidenceAmount
125,000,000 USD
ECB-at-date → €105M · rate 1.1863 on 2020-11-20
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
Nov 2020
Round type
series c
Amount (EUR)
€105M